EG
Last reporting period 30 Jun, 2024
Updated 19 Sep, 2024
Last price
—
Market cap $B
0.135
Exchange
XSTO - Nasdaq STOCKHOLM AB
35 %
Last period Growth rate volatility (2y)
What is Growth rate volatility (2y) ?
An indicator of the degree of volatility in the growth rate of a company's profit in the medium-term retrospective. A value below the average growth rate for the same period is the benchmark for calculating a company rating in Eyestock model.
See also Egetis Therapeutics
Company Analysis
EGTX.ST valuation, rating, competitors, insights and company profile
Eyestock Rating
EGTX.ST financial analysis by Eyestock methodology
Valuation
EGTX.ST valuation using historical relative method
Statements
EGTX.ST Income Statements, Balance Sheet and Cash Flow Statements
Dividends
EGTX.ST dividend yield and annual dividend
An indicator of the degree of volatility in the growth rate of a company's profit in the medium-term retrospective. A value below the average growth rate for the same period is the benchmark for calculating a company rating in Eyestock model.
Egetis Therapeutics`s Growth rate volatility (2y) for the period ended 2024-06-30 is 35 %
